Asep Medical Holdings Inc. (SEPSF)
Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions. The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc. Its corporate base of operations is located in Vancouver, Canada.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Biotechnology
Asep Medical Holdings Inc
OTC:SEPSFHealthcare · Biotechnology
Mkt Cap$118K
Float6.58M
O/S10.86M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Debt & Equity
Total Debt
Total Equity
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:10
Nasdaq bars a compliance period at 1:250
- 1:10Reverse splitApr 17, 202510 shares → 1
Balance Sheet Details
Accounts Receivable
Accounts Payable
Inventory
PP&E (Net)
Goodwill
Intangible Assets
Income Statement
Balance Sheet
Cash Flow Statement